… ; and (v) provided evidence for interactions of rosuvastatin with other drugs. … adverse effects
or drug-drug interactions associated with rosuvastatin treatment, were excluded. No clinical …

… reducing the risk of drug–drug interactions of these two statins … significant difference in
adverse effects between rosuvastatin … option for the management of dyslipidemia in HIV-infected …

… effects, as well. Taking into account its excellent safety profile and lack of clinically relevant
drug-drug interactions, the … , which contributes to the low-total incidence of adverse effects …

… best-tolerated agents for treating dyslipidemia, the common adverse events associated with
statin … Strategies to reduce drug–drug interactions with potential adverse effects should be …

… that can lead to potential drug–drug interactions (DDIs). … of cardiovascular events in patients
with dyslipidemia. While … life-threatening side effects in real clinical settings. Cases ranging …

… Rosuvastatin has been exhaustively evaluated in the setting … patients with primary
hyperlipidemia or mixed dyslipidemia; ii) for … with significant side effects and adverse events, the …

… for drug–drug interactions (DDIs). Large retrospective studies in various clinical settings
have … Although statin treatment is generally well-tolerated, the most common adverse effect is …

… It was estimated that rosuvastatin-associated absolute … of dyslipidemia and to reduce the
risk of cardiovascular (CV) … (CYP) system could result in fewer drug–drug interactions [13]. We …

… a low potential for pharmacokinetic drug—drug interactions. … As with other statins,
rosuvastatin-associated elevations in … treatment of patients with dyslipidemia. Additional …

… in a wide variety of drug–drug interactions. The major route of … adverse cardiovascular
events in a range of clinical settings. … report regarding rosuvastatin associated adverse effects, …